Skip to content
What Are Peptides

compounds explained simply

What Is GHK-Cu?

GHK-Cu is three amino acids with a copper atom attached, and it turns up on skin product labels. Here is what it actually is, why the copper is the interesting part, and what the evidence really supports.

GHK-Cu is a very small peptide — a chain of just three amino acids — with a single copper atom attached to it. A peptide is a short chain of amino acids, and amino acids are the small molecules your body links together to build proteins. Three is about as short as a peptide gets. It is not a laboratory invention either: GHK-Cu occurs naturally in human blood, where it was first identified in the early 1970s. Today you are most likely to meet the name on the ingredient list of a skin product. It has also been studied in wound healing. That is the plain answer, and the rest of this article unpacks it.

What does the name GHK-Cu actually mean?

This is one of the rare names in biochemistry that is honest about itself. It is not a brand or a code number. It is a list of the parts.

Chemists give every amino acid a single letter, so a chain can be written compactly. G is glycine. H is histidine. K is lysine. So GHK means glycine, then histidine, then lysine, joined end to end. The K looks arbitrary, and it is — L had already gone to leucine.

Cu is the chemical symbol for copper, taken from cuprum, the Latin word. It is the same Cu you would see on a periodic table or stamped on plumbing fittings. Put it together and the name reads: glycine-histidine-lysine, plus copper. Nothing hidden. Here is a case where the name is simply a description of the object.

One distinction is worth carrying with you. GHK on its own means the peptide alone. GHK-Cu means the peptide with its copper. Most research tests the pair.

Why is there a copper atom attached?

This is the most interesting idea in the subject, and it is not complicated once someone says it plainly. Copper is essential to you, and without any you would become seriously ill. But loose copper is also destructive. It is chemically reactive, and when it sits around unattached it drives reactions that produce damaging molecules. The same reactivity that makes copper useful is what makes it dangerous unsupervised.

Your body's answer is not to store copper somewhere safe. It is never to let copper travel alone. From the moment it is absorbed until it reaches where it is needed, copper is held by something — passed from one carrier molecule to the next, with almost none drifting free.

Think of a dish coming out of a hot oven. Nobody thinks the dish is bad — it is dinner, and the heat is the point. But you do not pick it up bare-handed. There is always something between the heat and the skin: a mitt, a handle, a board. The mitt does not change the dish. It just makes the dish possible to move, and to hand to someone else.

That is roughly how your body treats copper, and GHK appears to be one of the mitts. The three amino acids form a pocket that grips a copper atom firmly enough to stop it wandering, but not so firmly that it can never be handed on 2. Both halves matter. A carrier that grips too weakly never picks anything up. One that grips too tightly becomes a dead end rather than a delivery.

Be careful here, though. That GHK can hold copper is settled chemistry. That it actually serves as a copper carrier inside a living human body is a well-argued idea rather than a demonstrated fact.

Three rounded beads joined in a short chain, curving inward to cradle one smaller circle held between them
Three amino acids holding one copper atom. The peptide is the carrier. The copper is the thing being carried.

What does your body use copper for?

Mostly, copper is used by enzymes. An enzyme is a protein that speeds up one particular chemical reaction — a specialized tool that does a single job, over and over. A handful of your enzymes have a copper atom built into them and simply do not work without it. The copper is not decoration. It is the working part, the way the blade is the working part of a pair of scissors.

One of those enzymes matters here. It helps strengthen collagen — the main structural protein in skin, and the material that gives tendons and blood vessel walls their strength and springiness. When people talk about skin losing firmness, collagen is what they mean.

Making collagen takes two steps. Your cells produce the strands, and then those loose strands have to be locked to each other. That is what turns separate threads into something that bears a load — the difference between a pile of rope and a net. The enzyme doing that locking needs copper.

So there is a tidy line of reasoning behind the interest. GHK carries copper, copper switches on enzymes, one of those enzymes strengthens collagen, and collagen is what skin is structurally made of. Every link is real. What a tidy chain does not tell you is whether much of it happens when someone puts a peptide on their face.

What does the research actually show?

The useful move is to sort the evidence by what kind it is, because different kinds support very different claims. Start with cells in a dish. Researchers grow human skin cells in a shallow dish of nutrient liquid, add the compound, and measure what the cells produce. In 1988 a study reported that GHK-Cu increased collagen production in exactly this setup 1. Later work extended the finding to other structural materials skin is built from 23. As claims about this compound go, that one has held up.

Now the limitation. A dish is a simplified world. There is no blood supply, no immune system, no skin barrier, and the compound is dropped straight onto the cells. Such a study shows that the cells can respond. It does not show that anything reaches those cells in a living person.

Research in actual people is thinner than the marketing suggests. It is almost entirely about creams applied to skin, in studies that tend to be small and short, measuring how skin looks and feels.

Why does that count for less than it sounds? Because a cream study tests a cream, not a molecule. The tube also holds water, oils and other ingredients, and simply moisturizing skin makes it look better. If skin improves during a study, the result is genuine — but it belongs to the whole product. Working out which ingredient earned the credit takes a comparison most of these studies do not include.

There is a second gap, quieter but larger. "Skin looked smoother" and "collagen was rebuilt underneath" are different claims, and only the first was measured. The leap between them happens in the marketing copy, not in the study.

  • Chemistry: GHK holds onto copper. Well established and not seriously disputed.
  • Cells in a dish: GHK-Cu increases collagen production, reported repeatedly.
  • Animals: wound-healing work exists, mostly in rodents, and animal results do not automatically carry over.
  • People: small, short studies of skin creams, judged largely on appearance.
  • Anything beyond skin in people: essentially unstudied.

Does it even get through your skin?

Skin's main job is to be a barrier. Its outer layer is a dense wall of dead, flattened cells packed with fats, built to hold water in and keep the world out. It is very good at this, which is inconvenient for anyone hoping to deliver something through it.

This has been measured rather than argued about. Researchers took pieces of human skin in the laboratory and tracked how much of the copper tripeptide reached each layer 4. Some gets past the surface, and the amount drops the deeper you look. So "does it get through" has no single answer. It depends on how deep you are asking about.

That matters because the cells that make collagen do not live on the surface. A letter pushed through a building's front door has not necessarily reached the apartment on the fourth floor. This is not a knock on the compound — every skin product faces the same wall. It is a reminder that an ingredient on a label is a claim about the tube, not about where it ends up.

Why does it matter who did the research?

One feature of this literature deserves stating plainly, because it changes how much weight the pile of papers carries. Across roughly fifty years, an unusually large share of the published work on this compound involves the same researcher — who has also held commercial interests in copper-peptide products 23.

Read that carefully, because it is easy to over-read. It is not an accusation of dishonesty, and it does not mean the findings are wrong. Plenty of real discoveries have been carried for decades by one determined person, especially small molecules nobody can patent.

Here is why it matters anyway. Science corrects itself mainly through other people. Someone with no stake runs the same experiment and reports whatever comes out, and a result that survives that is far more trustworthy than one that never faced it. When most of a field's output comes from one source, that check has largely not happened. A claim repeated in twenty papers by the same group is one line of evidence, not twenty.

This is why the collagen result keeps getting singled out. The 1988 work was a collaboration with an independent group, with their own laboratory and no stake in the compound's reputation 1. The habit to take away is a question you can ask about any health claim: who else has found this?

What about the claim that levels drop with age?

You will run into this one constantly. The reported finding is that the amount of GHK in blood is higher in young adults and lower in older ones, falling by roughly half over a few decades 3.

It is easy to see why that grabs people. Repair slows as we age, and here is a repair-associated molecule that also declines with age. The conclusion seems to write itself: the drop causes the slowdown, so putting it back should reverse it.

But two things changing together does not mean one causes the other. The number of umbrellas on a street goes up whenever the pavement gets wet. The umbrellas did not wet the pavement. Something else caused both.

Applied here, there are three possibilities the measurement cannot tell apart. The decline might drive the slowdown in repair. Or the slowdown might drive the decline, if tissue doing less also makes less of this. Or aging might cause both independently.

And even if the arrow points the way people hope, a step is still being skipped. Restoring a supply does not automatically undo what happened while it was low. Turning the water back on does not revive a plant that already died. Whether topping something up reverses a consequence is a separate question, and that experiment has not been done in people.

So what should you make of it?

The honest summary is shorter than either the enthusiasm or the eye-rolling. There is real chemistry, and it is the strongest part: a tiny natural peptide that holds copper, in a body with good reason to keep copper carried rather than loose. There is a real, repeated finding in cells grown in a dish. There is a modest human record, almost all of it about creams and how skin looks. And there is a popular story running well ahead of all three.

That is not a scandal. It is what most science looks like up close — a solid narrow finding, a plausible bigger idea, and a gap nobody has closed. The trouble starts when the bigger idea is sold with the confidence the narrow finding earned.

So sort a claim before you weigh it. Copper binding is chemistry. Smoother-looking skin is a small cream study. Anything grander is, for now, a hope rather than a result — and knowing which one you are being handed is most of the skill.

References

  1. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+FEBS Letters, 1988
  2. The human tri-peptide GHK and tissue remodelingJournal of Biomaterials Science, Polymer Edition, 2008
  3. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene DataInternational Journal of Molecular Sciences, 2018
  4. Human skin penetration of a copper tripeptide in vitro as a function of skin layerInflammation Research, 2011